Biochemistry vs. bio-terrorism.(NEWS/NOUVELLES)(Twinstrand Therapeutics contract with United States. Department of Defense)(Brief article)

Canadian Chemical News, July, 2007 by Thorbes, Carol

Twinstrand Therapeutics of Burnaby, BC, has won a $2.2 million, two-year American contract to develop an antidote to ricin poisoning. The contract is with a U.S. Department of Defense agency. A highly toxic protein derived from the widely available castor bean plant, ricin ranks high on the world's list of feared and deadly bioterror agents. There currently is no antidote to ricin. Intelligence reports indicate ricin was used during the Iran-Iraq war in the 1980s and stockpiled by al-Qaeda terrorists in Afghanistan.

Twinstrand's founder, Thor Borgford, MCIC, is an adjunct professor in the Simon Fraser University departments of chemistry and molecular biology and biochemistry.

"During the past decade, Twinstrand has developed unparalleled expertise...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here